预测耐受呼吸暂停试验的缺氧阈值:评估神经学标准死亡时
该回顾性队列研究纳入2010至2022年Tel Aviv医疗中心70例疑似脑死亡并接受呼吸暂停试验(AT)的患者,主要终点为AT结束时动脉血氧分压(PaO2)≤60 mmHg。7例达到主要终点,其试验前PaO2中位数243.7 mmHg,显著低于未达到者的374.8 mmHg(P=0.0041)。试验前PaO2对AT结束时低PaO2有良好判别能力,ROC曲线下面积0.76(95%CI 0.52-0.99)。作者结论认为,AT结束时PaO2与试验开始时PaO2密切相关,设定试验开始时PaO2约300 mmHg的切点可能有助于避免饱和度降至90%以下。
要点
- 在70例接受呼吸暂停试验的疑似脑死亡患者中,7例于试验结束时PaO2≤60 mmHg。
- 试验结束时PaO2≤60 mmHg者试验前PaO2中位数243.7 mmHg,显著低于未达标者的374.8 mmHg(P=0.0041)。
- 试验前PaO2判别试验结束时低PaO2的ROC曲线下面积为0.76(95%CI 0.52-0.99)。
- 作者认为,启动呼吸暂停试验时PaO2约300 mmHg的切点可能有助于避免饱和度降至90%以下。
适用人群与场景
- 疑似脑死亡、在Tel Aviv医疗中心2010至2022年接受呼吸暂停试验的患者70例。
诊断标准与关键阈值
- 主要终点:呼吸暂停试验结束时动脉血氧分压(PaO2)≤60 mmHg;原文指出该阈值是饱和度曲线偏转点,可能导致患者氧饱和度快速恶化。
- 作者提出:启动呼吸暂停试验时PaO2约300 mmHg作为切点,可能有助于避免饱和度降至90%以下。
红旗征与不能漏的情况
- 呼吸暂停试验可因低氧血症和血流动力学不稳定等安全顾虑而中止,以防病情恶化。
研究设计与关键结果
- 回顾性队列研究,纳入2010至2022年Tel Aviv医疗中心70例接受呼吸暂停试验的疑似脑死亡患者,主要终点为试验结束时PaO2≤60 mmHg,共7例达到主要终点。
- 试验结束时PaO2≤60 mmHg者试验前PaO2中位数243.7 mmHg(四分位距104.65-307.00),显著低于未达标者的374.8 mmHg(四分位距267.8-444.9),P=0.0041。
- 试验前PaO2判别试验结束时低PaO2的ROC曲线下面积0.76(95%CI 0.52-0.99)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,启动呼吸暂停试验时PaO2约300 mmHg的切点可能有助于避免饱和度降至90%以下;原文未据此给出其他推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The apnea test (AT) plays a vital role in diagnosing brain death by evaluating the absence of spontaneous respiratory activity. It entails disconnecting the patient from mechanical ventilation to raise the CO2 partial pressure and lower the pH. Occasionally, the AT is aborted because of safety concerns, such as hypoxemia and hemodynamic instability, to prevent worsening conditions. However, the exact oxygen partial pressure level needed before commencing AT, indicating an inability to tolerate the test, is still uncertain. This study seeks to determine pre-AT oxygen levels linked with a heightened risk of test failure.
METHODS: We conducted a retrospective cohort study involving patients suspected of having brain death at the Tel Aviv Medical Center from 2010 to 2022. The primary outcome was defined as an arterial partial O2 pressure (PaO2) level of 60 mmHg or lower at the conclusion of the AT. This threshold is significant because it marks the point at which the saturation curve deflects, potentially leading to rapid deterioration in the patient's oxygen saturation.
RESULTS: Among the 70 patients who underwent AT, 7 patients met the primary diagnostic criteria. Patients with a PaO2 ≤ 60 mmHg at the conclusion of the AT exhibited a significantly lower initial median PaO2 of 243.7 mmHg compared with those with higher pre-AT PaO2 levels of 374.8 mmHg (interquartile range 104.65-307.00 and interquartile range 267.8-444.9 respectively, P value = 0.0041). Pre-AT PaO2 levels demonstrated good discriminatory ability for low PaO2 levels according to the receiver operating characteristic (ROC) curve, with an area under the curve of 0.76 (95% confidence interval 0.52-0.99).
CONCLUSIONS: PaO2 values at the conclusion of the AT are closely associated with PaO2 values at the beginning of the test. Establishing a cutoff value of approximately 300 mmHg PaO2 at the onset of AT may assist in avoiding saturation drops below 90%.
参考来源
- Aviram D, Hikri D, Aharon M, et al. Predictive Hypoxemic Threshold for Tolerating the Apnea Test While Assessing Death by Neurological Criteria. Neurocrit Care. 2024. PMID: 39300039. doi:10.1007/s12028-024-02105-z
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。